Aldebaran Capital’s Eli Lilly LLY Stock Holding History

Aldebaran Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.8M	Hold	9,007	–	–	8.12%	2
2026 Q1	$8.28M	Sell	9,007 -25	-0.3%	-$25.3K	6.33%	4
2025 Q4	$9.71M	Buy	9,032 +1,249	+16%	+$1.19M	8.7%	2
2025 Q3	$5.94M	Hold	7,783	–	–	5.45%	5
2025 Q2	$6.07M	Hold	7,783	–	–	5.99%	5
2025 Q1	$6.43M	Hold	7,783	–	–	6.08%	5
2024 Q4	$6.01M	Hold	7,783	–	–	5.71%	6
2024 Q3	$6.9M	Hold	7,783	–	–	6.29%	5
2024 Q2	$7.05M	Hold	7,783	–	–	6.56%	5
2024 Q1	$6.05M	Hold	7,783	–	–	5.77%	5
2023 Q4	$4.54M	Hold	7,783	–	–	4.64%	9
2023 Q3	$4.18M	Sell	7,783 -50	-0.6%	-$25.8K	4.26%	9
2023 Q2	$3.67M	Hold	7,833	–	–	3.77%	10
2023 Q1	$2.69M	Sell	7,833 -50	-0.6%	-$16.9K	2.75%	13
2022 Q4	$2.88M	Buy	+7,883	New	+$2.79M	2.98%	13

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aldebaran Capital's LLY Position: Q2 2026 in Review

Aldebaran Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 9,007 shares worth $10.8M. The position accounts for 8.12% of the portfolio, ranked #2.

Aldebaran Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Aldebaran Capital held 9,007 shares of Eli Lilly worth $10.8M as of Q2 2026.
Aldebaran Capital left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 8.12% of Aldebaran Capital's portfolio in Q2 2026, its #2 holding.
Aldebaran Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aldebaran Capital's 13F filing for Q2 2026, filed 14 Aug 2026.